Nouscom Highlights Potential of NOUS-209 to Intercept Cancer in Lynch Syndrome Carriers in Seminal Nature Medicine Publication
BASEL, Switzerland – January 16, 2026 – Nouscom, a clinical-stage biotech company developing next-generation immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease, today announced that results from its Phase 1b/2 clinical trial of NOUS-209 in Lynch Syndrome (LS) carriers have been published in Nature Medicine (D’Alise et al). Publication […]
IntelyCare Acquires CareRev to Create Comprehensive Workforce Staffing Platform for Health Systems
BOSTON, Jan. 8, 2026 /PRNewswire/ — IntelyCare, a leading technology-enabled healthcare staffing platform, today announced the acquisition of CareRev, the on-demand workforce platform purpose-built for acute care. The acquisition brings together two of the industry’s most experienced operators in healthcare workforce management, creating one of the most comprehensive clinical labor solutions in the market. The acquisition positions the combined […]
Healthcare Investing in 2025: Discipline Returned—and the Five Forces Shaping 2026
2025 marked a clear inflection point for healthcare investing—not because capital fully returned, but because discipline did. Liquidity remained constrained, fundraising became more selective, and exit pathways narrowed, forcing both investors and operators to adapt. As a result, healthcare companies are now being built, financed, and evaluated under a far more rigorous set of expectations […]
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
SAN CARLOS, Calif.–(BUSINESS WIRE)–Dren Bio, a privately held, clinical-stage biotechnology company developing first-in-class myeloid cell engager therapeutics, announced today that it has entered into a strategic collaboration with Sanofi (NASDAQ: SNY) for the discovery and development of a next-generation B-cell depleting therapy for the treatment of various autoimmune diseases. The new agreement builds on the […]
GSK spins out corporate VC fund focused on bioelectronic tech
GSK has offloaded a corporate venture unit that invests in bioelectronic startups working on neuromodulation, wearables, implanted devices and other technology, Endpoints News has learned. The VC unit, Action Potential Venture Capital (APVC), launched with $50 million from GSK in 2013, when it made its first investment in SetPoint Medical, creator of an implantable device […]
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
BOSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) — Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced positive results from the Phase 2 SUMIT-BC clinical trial evaluating samuraciclib in combination with fulvestrant in patients with second-line advanced hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) […]
YPrime Wins Two Clinical Trials Arena Excellence Awards for Innovation in AI and Sustainable Practices
MALVERN, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) — YPrime, a proven leader in clinical trial technology, today announced it has received two distinctions in the 2025 Clinical Trials Arena Excellence Awards: Innovation for AI in Clinical Trials and Environmental Excellence for Sustainable Trials. Powered by GlobalData’s independent research, the Clinical Trials Arena Excellence Awards recognize organizations […]
Celebrating Over Ten Years of Success in Healthcare
We are excited to celebrate over a decade of remarkable growth and success at Revelation Partners—made possible by the enduring partnership and support of our limited partners, trusted counterparties, and friends of the firm. Over the past ten years, our team and platform have expanded significantly, and we are deeply grateful to everyone who has […]
Bluejay Capital Partners Recapitalizes Quality Life Science Logistics & Transportation
DENVER & COOPERSVILLE, Mich., December 02, 2025–(BUSINESS WIRE)–Bluejay Capital Partners, LLC (Bluejay Capital), a specialist in partnering and investing in transportation and logistics businesses, has recapitalized Quality Life Science Logistics & Transportation (QLS), a premier provider of specialized cold chain transportation and logistics solutions for the pharmaceutical and life sciences industries. Terms of the transaction were not disclosed. […]
Aspen enriches Parkinson’s cell therapy trial with Kite-backed $115M series C
Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The raise will power Aspen’s phase 1/2 study of ANPD001, a therapy that turns patients’ skin cells into new neurons that are then transplanted into their brains to […]